Innoviz (INVZ) CBO Hofstetter details share, option and RSU holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Innoviz Technologies Ltd. Chief Business Officer Hofstetter Elad Ben filed an initial statement of beneficial ownership, detailing his equity position in the company. He holds 232,144 Ordinary Shares directly and multiple option grants over additional ordinary shares at exercise prices ranging from $0.5695 to $8.5000, with expirations between 2028 and 2032.
The filing also notes 143,906 Ordinary Shares issuable upon vesting of restricted share units, granted between August 2022 and November 2025, with vesting schedules that generally run quarterly through 2029 or 2028. Vesting and unvested options are conditioned on Hofstetter continuing as a service provider to Innoviz on each vesting date. This Form 3 does not report any new purchases or sales, only existing holdings and equity awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Hofstetter Elad Ben
Role
Chief Business Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option — 21,072 shares (Direct);
Ordinary Shares — 232,144 shares (Direct)
Footnotes (1)
- Includes 143,906 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 3,564 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 11,388 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 12,288 RSUs granted February 27, 2024, with 2,384 vesting quarterly through 2027 and 9,904 vesting quarterly through 2028; (d) 23,430 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 12,372 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,072 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder vesting quarterly through 2029; and (g) 39,792 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable. Immediately exercisable. Share options granted on August 9, 2022. Includes 18,718 vested options, and 2,674 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Share options granted on August 1, 2023. Includes 16,750 vested options, and 10,050 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Share options granted on August 20, 2024. Includes 15,060 vested options, and 25,100 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Share options granted on August 5, 2025. Includes no vested options, and 44,016 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
FAQ
What does this Form 3 filing show for Innoviz (INVZ)?
The Form 3 shows the initial equity holdings of Chief Business Officer Hofstetter Elad Ben. It lists his direct Ordinary Share ownership, outstanding stock options with various exercise prices and expirations, and a large block of RSUs scheduled to vest through 2029.
What stock options are reported for the Innoviz (INVZ) Chief Business Officer?
The filing lists several option grants over Innoviz Ordinary Shares with exercise prices from $0.5695 to $8.5000. These options expire between 2028 and 2032 and cover tens of thousands of underlying shares across multiple grant dates and vesting schedules.
How many RSUs does Hofstetter hold in Innoviz (INVZ) and how do they vest?
Hofstetter holds 143,906 Restricted Share Units tied to Innoviz Ordinary Shares. These RSUs were granted between August 2022 and November 2025 and generally vest quarterly through 2028 or 2029, contingent on his continued service with the company.
Does this Innoviz (INVZ) Form 3 show any insider buying or selling?
No, the Form 3 does not show any insider buying or selling transactions. All entries are classified as holdings, with the transaction summary indicating neutral net buy/sell direction and zero recorded purchases, sales, exercises, gifts, or tax-withholding dispositions.
What conditions apply to the Innoviz (INVZ) options and RSUs reported?
The options and RSUs generally vest only if Hofstetter remains a service provider to Innoviz. Several footnotes state that unvested options and RSUs vest in equal quarterly installments through specified years, subject to continued service on each applicable vesting date.